Sector consensus Bright Minds Biosciences Inc.
Equities
DRUG
CA10919W4056
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.31 CAD | 0.00% |
|
-2.94% | -5.54% |
| 01-09 | Bright Minds Biosciences Closes its US$175 Million Public Offering | MT |
| 01-09 | Bright Minds Biosciences Closes $175.1 Million Stock Offering | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | CA$121 | +16% | 4 | ||||||
| CHF 673.39 | +30.2% | 23 | ||||||
| US$405.42 | +14.55% | 24 | ||||||
| ₩249,772.73 | +13.53% | 22 | ||||||
| US$247.35 | +31.93% | 20 | ||||||
| US$119.37 | +22.44% | 19 | ||||||
| US$545.75 | +0.68% | 12 | ||||||
| €70.26 | +3.32% | 15 | ||||||
| US$91.13 | +5.35% | 22 | ||||||
| US$233.91 | +24.15% | 16 | ||||||
| US$206.38 | +37.04% | 16 | ||||||
| US$54.46 | +6.89% | 14 | ||||||
| US$75.25 | +12.68% | 12 | ||||||
| US$87.92 | +60.11% | 12 | ||||||
| Average | 18,050.31 | +19.92% | 16 | ||||||
| Weighted average by Cap. | 30,762.2 | +20.62% | 19 |
- Stock Market
- Equities
- DRUG Stock
- Sector Bright Minds Biosciences Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition